NLRP3 and hyperuricemia: Preclinical evidence suggests that hyperuricemia may exacerbate RA autoimmune pathogenesis through dual mechanisms: crystal-dependent NLRP3 inflammasome activation and crystal-independent enhancement of Th17 differentiation (14).